Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Botanix Pharmaceuticals Limited ( (AU:BOT) ).
Botanix Pharmaceuticals Ltd announced the cessation of 2,404,747 securities due to the expiry of options without exercise or conversion as of May 21, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Ltd operates in the pharmaceutical industry, focusing on the development and commercialization of dermatology and antimicrobial products. The company is known for its innovative approach in addressing unmet needs in skin health and infection control.
Average Trading Volume: 10,602,119
Technical Sentiment Signal: Hold
Current Market Cap: A$732.7M
For detailed information about BOT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue